Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CRH Medical (CRHM) initiated with a Buy at Canaccord due to the company's position for significant growth in the highly fragmented anesthesia service market. 2. Columbia Pipeline Group (CPGX) initiated with a Neutral at Goldman. 3. Boston Scientific (BSX) initiated with a Buy at Nomura. 4. Lockheed Martin (LMT) initiated with a Buy at Berenberg. 5. Rice Midstream (RMP) initiated with a Buy at Stifel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Deutsche Bank raised the firm's price target on Lockheed Martin to $487 from $467 and keeps a Hold rating on the shares. The company reported solid Q1 results, the analyst tells investors in a research note. The firm says that while the Street mis-modeling the extra week played a part in this quarter's outperformance versus sell-side estimates, "there were also pockets of fundamental outperformance." It sees upside to full-year sales estimates.

Stifel raised the firm's price target on Boston Scientific to $83 from $70 and keeps a Buy rating on the shares. The firm said the company delivered "solid" Q1 outperformance, underpinned by "important" new product launches. Looking ahead to 2024 and beyond, Stifel believes Boston Scientific could continue outperforming their Loan Repayment Program and the firm's projections.

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here

Lockheed Martin was awarded a $102.06M cost-plus-incentive-fee modification to previously-awarded contract for capability package development and fielding, system integration and fielding, and in-service sustainment in support of current configurations of the AEGIS combat system. Work is expected to be completed by December 31. The Naval Sea Systems Command is the contracting activity.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

During its earnings conference call, Lockheed Martin says expectations for FY24 remain unchanged. Will reassess guidance by the end of Q2. Says company off to a solid start in 2024. Thinking of 2025, has higher confidence on continued growth. Sees potential "re-balance of the workforce." Expects "stable growth" over the next five years.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here

Backs FY24 free cash flow view $6B-$6.3B; FY24 CapEx view ~$1.75B.

Backs FY24 revenue view $68.5B-$70B, consensus $69.51B.